Kodiak Sciences Inc.

Kodiak Sciences Inc.verified

KOD

Price:

$3.05

Market Cap:

$160.23M

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry ...[Read more]

Industry

Biotechnology

IPO Date

2018-10-04

Stock Exchange

NASDAQ

Ticker

KOD

The PE Ratio as of July 2024 (TTM) for Kodiak Sciences Inc. (KOD) is -0.69

According to Kodiak Sciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.69. This represents a change of -23.89% compared to the average of -0.91 of the last 4 quarters.

Kodiak Sciences Inc. (KOD) Historical PE Ratio (quarterly & annually)

How has KOD PE Ratio performed in the past?

The mean historical PE Ratio of Kodiak Sciences Inc. over the last ten years is -19.37. The current -0.69 PE Ratio has changed 256.30% with respect to the historical average. Over the past ten years (40 quarters), KOD's PE Ratio was at its highest in in the September 2023 quarter at -0.47. The PE Ratio was at its lowest in in the December 2019 quarter at -45.52.

Quarterly (TTM)
Annual

Average

-19.37

Median

-12.70

Minimum

-58.29

Maximum

-0.61

Kodiak Sciences Inc. (KOD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kodiak Sciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.17%

Maximum Annual PE Ratio = -0.61

Minimum Annual Increase = -93.19%

Minimum Annual PE Ratio = -58.29

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.61-45.42%
2022-1.12-93.19%
2021-16.45-67.43%
2020-50.49-13.38%
2019-58.292.17%
2018-2.57-73.43%
2017-9.66-38.67%

Kodiak Sciences Inc. (KOD) Average PE Ratio

How has KOD PE Ratio performed in the past?

The current PE Ratio of Kodiak Sciences Inc. (KOD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.06

5-year avg

-25.39

10-year avg

-19.37

Kodiak Sciences Inc. (KOD) PE Ratio vs. Peers

How is KOD’s PE Ratio compared to its peers?

Kodiak Sciences Inc.’s PE Ratio is greater than Reviva Pharmaceuticals Holdings, Inc. (-0.94), greater than Eyenovia, Inc. (-2.04), greater than Cognition Therapeutics, Inc. (-2.13), less than TransCode Therapeutics, Inc. (-0.09), greater than Assembly Biosciences, Inc. (-1.59), less than Instil Bio, Inc. (-0.67), greater than Neoleukin Therapeutics, Inc. (-0.98), less than Spero Therapeutics, Inc. (3.17), less than CytomX Therapeutics, Inc. (6.95), greater than Checkpoint Therapeutics, Inc. (-1.58), less than Mustang Bio, Inc. (-0.09), greater than Reviva Pharmaceuticals Holdings, Inc. (-0.94), greater than Fortress Biotech, Inc. (-0.73), greater than Intercept Pharmaceuticals, Inc. (-13.55), greater than Madrigal Pharmaceuticals, Inc. (-12.80), less than Sarepta Therapeutics, Inc. (813.14), greater than Mirati Therapeutics, Inc. (-5.32), greater than Biomea Fusion, Inc. (-1.52), greater than Stoke Therapeutics, Inc. (-6.15), greater than Akero Therapeutics, Inc. (-8.95), less than Homology Medicines, Inc. (-0.01), greater than Gossamer Bio, Inc. (-1.40),

Build a custom stock screener for Kodiak Sciences Inc. (KOD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kodiak Sciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kodiak Sciences Inc. (KOD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kodiak Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Kodiak Sciences Inc.'s PE Ratio?

How is the PE Ratio calculated for Kodiak Sciences Inc. (KOD)?

What is the highest PE Ratio for Kodiak Sciences Inc. (KOD)?

What is the 3-year average PE Ratio for Kodiak Sciences Inc. (KOD)?

What is the 5-year average PE Ratio for Kodiak Sciences Inc. (KOD)?

How does the current PE Ratio for Kodiak Sciences Inc. (KOD) compare to its historical average?